|
1.
|
2023/04/17
|
|
Changes in vaccination administration in Japan
|
|
2.
|
2022/12/15
|
|
Immunogenicity of Catch-Up Immunization with Conventional Inactivated Polio Vaccine among Japanese Adults
|
|
3.
|
2022/12/06
|
|
Recent Trend of Antimicrobial Susceptibility among Mycoplasma pneumoniae Isolated from Japanese Children
|
|
4.
|
2022/10/12
|
|
Proposal for the revision of guidelines for clinical trials of vaccines to prevent infectious diseases in Japan
|
|
5.
|
2022/09/12
|
|
Changes in serum antibody titers after vaccination for COVID-19 and evaluation of post-vaccination health conditions
|
|
6.
|
2022/07/08
|
|
Acceptance of Booster COVID-19 Vaccine and Its Association with Components of Vaccination Readiness in the General Population: A Cross-Sectional Survey for Starting Booster Dose in Japan
|
|
7.
|
2022/04
|
|
Proposal for the revision of the guidelines for Non-clinical studies of vaccines for the prevention of infectious diseases in Japan
|
|
8.
|
2022/01/05
|
|
Incidence of Mumps Deafness in Japan, 2005-2017: Analysis of Japanese Insurance Claims Database
|
|
9.
|
2021/10
|
|
The safety and efficacy of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate for Inhalation Suspension Set in children under the age of 5 in a post-marketing surveillance
|
|
10.
|
2021/08/09
|
|
Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol
|
|
11.
|
2021/01/03
|
|
Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: A test-negative case-control study in Japan.
|
|
12.
|
2020/11
|
|
Low prevalence of Chlamydia pneumoniae infections during the Mycoplasma pneumoniae epidemic season: Results of nationwide surveillance in Japan
|
|
13.
|
2020/04/06
|
|
Immune thrombocytopenic purpura risk by live, inactivated and simultaneous vaccinations among Japanese adults, children and infants: a matched case–control study, Japan．
|
|
14.
|
2020/03/02
|
|
Disaster Assistance for Maintaining Foreign Residentsʼ Health
|
|
15.
|
2019/07/24
|
|
Characterization of an unusual DS-1-like G8P[8] rotavirus strain from Japan in 2017: Evolution of emerging DS-1-like G8P[8] strains through reassortment.
|
|
16.
|
2019/07
|
|
Comparing Antimicrobial Susceptibilities among Mycoplasma pneumoniae Isolates from Pediatric Patients in Japan between Two Recent Epidemic Periods
|
|
17.
|
2018/12
|
|
Communication Issues Faced by Foreign Patients in Receiving Medical Care in Japan
|
|
18.
|
2018/10
|
|
Effects of a public subsidization program for mumps vaccine on reducing the disease burden in Nagoya City, Japan
|
|
19.
|
2018/08
|
|
A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan
|
|
20.
|
2018/08
|
|
A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
|
|
21.
|
2018/05
|
|
Characterization of unusual DS-1-like G3P[8] rotavirus strains in children with diarrhea in Japan
|
|
22.
|
2017/11
|
|
Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix(R)) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen(R)) for Japanese travelers to endemic countries
|
|
23.
|
2017/10
|
|
Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015
|
|
24.
|
2017/08
|
|
Control selection and confounding factors: A lesson from a Japanese case-control study to examine acellular pertussis vaccine effectiveness
|
|
25.
|
2017/08
|
|
Vaccine epidemiology: Its role in promoting sound immunization programs in Japan
|
|
26.
|
2017/07
|
|
Changes in rotavirus genotypes before and after vaccine introduction: a multicenter, prospective observational study in three areas of Japan
|
|
27.
|
2017/05
|
|
Histological findings in severe Mycoplasma pneumoniae pneumonia.
|
|
28.
|
2016/11
|
|
Inhaled Laninamivir Octanoate as Prophylaxis for Influenza in Children
|
|
29.
|
2016/11
|
|
Rotavirus vaccine and health-care utilization for rotavirus gastroenteritis in Tsu City, Japan
|
|
30.
|
2016/08
|
|
Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic.
|
|
31.
|
2016/05
|
|
Rapid diagnostic method for the identification of Mycoplasma pneumoniae respiratory tract infection
|
|
32.
|
2016/04
|
|
Symposium report of the 17th annual meeting of the Japanese Society for Vaccinology, 2013 - Bacterial vaccines: Effectiveness and issues
|
|
33.
|
2016/03
|
|
Macrolide Therapy for Prevention of Exacerbation in Individuals with Diffuse Aspiration Bronchiolitis
|
|
34.
|
2015/07
|
|
Antibody responses of Chlamydophila pneumoniae pneumonia: Why is the diagnosis of C. pneumoniae pneumonia difficult?
|
|
35.
|
2015/07
|
|
Detection failure rate of chest radiography for the identification of nursing and healthcare-associated pneumonia
|
|
36.
|
2015/07
|
|
Reactogenicity of trivalent inactivated influenza vaccine in young children: Pronounced reactions by previous successive vaccinations.
|
|
37.
|
2015/06
|
|
Diagnostic sensitivity of a rapid antigen test for the detection of Mycoplasma pneumoniae: Comparison with real-time PCR
|
|
38.
|
2015/03
|
|
Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults
|
|
39.
|
2015/02
|
|
Effectiveness of acellular pertussis vaccine in a routine immunization program: A multicenter, case-control study in Japan
|
|
40.
|
2015/02
|
|
Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
|
|
41.
|
2014/07
|
|
Spread of viral infection to family members from influenza patients treated with a neuraminidase inhibitor
|
|
42.
|
2014/04
|
|
Management of refractory Mycoplasma pneumoniae pneumonia: Utility of measuring serum lactate dehydrogenase level
|
|
43.
|
2014/04
|
|
The exacerbation risk prediction by fractional exhaled nitric oxide in younger and elder children with bronchial asthma
|
|
44.
|
2014/01
|
|
Chest computed tomography for the diagnosis of Mycoplasma pneumoniae infection
|
|
45.
|
2013/10
|
|
Infection Control (Symposium I: International Cooperation for Health and "Nutrition")
|
|
46.
|
2013/09
|
|
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan
|
|
47.
|
2013/08
|
|
Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients
|
|
48.
|
2013/06
|
|
Safety evaluation of laninamivir octanoate hydrate through analysis of adverse events reported during early post-marketing phase vigila
|
|
49.
|
2013/05
|
|
Therapeutic Efficacy of Macrolides, Minocycline, and Tosufloxacin against Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Pediatric Patients
|
|
50.
|
2013/03
|
|
A study on the HA amount of HA influenza vaccination on efficacy and safety in infants
|
|
51.
|
2013/01
|
|
How to write a certification form of previous vaccination and records of diseases
|
|
52.
|
2013/01
|
|
Safety evaluation of laninamivir octanoate hydrate through analysis of adverse events reported during early post-marketing phase vigilance
|
|
53.
|
2012/11
|
|
In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study
|
|
54.
|
2011/11
|
|
Rotavirus-associated acute gastroenteritis hospitalizations among Japanese children aged <5 years: Active rotavirus surveillance in Mie prefecture, Japan
|
|
55.
|
2011/07
|
|
Japanese vaccinations and practices, with particular attention to polio and pertussis.
|
|
Display 5 items
|
|
Display all(55)
|
